Holen Sie sich die Stockscreener-App
4.67
1.74%
0.08
Handel nachbörslich:
4.68
0.010
+0.21%
Schlusskurs vom Vortag:
$4.59
Offen:
$4.64
24-Stunden-Volumen:
4.45M
Relative Volume:
1.63
Marktkapitalisierung:
$768.74M
Einnahmen:
$296.15M
Nettoeinkommen (Verlust:
$24.02M
KGV:
38.72
EPS:
0.1206
Netto-Cashflow:
$127.01M
1W Leistung:
+11.19%
1M Leistung:
+31.92%
6M Leistung:
+126.70%
1J Leistung:
+403.40%
1-Tages-Spanne:
$4.555
$4.73
1-Wochen-Bereich:
$4.0802
$4.73
52-Wochen-Spanne:
$0.5271
$5.78
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Firmenname
Ironwood Pharmaceuticals Inc
Sektor
Telefon
617-621-7722
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Compare IRWD vs TAK, ZTS, TEVA, HLN, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
4.67 | 755.58M | 296.15M | 24.02M | 127.01M | 0.1206 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-04-15 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-08-08 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-09 | Eingeleitet | Jefferies | Buy |
| 2023-09-28 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-02 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Eingeleitet | Northland Capital | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Hochstufung | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Sell |
| 2018-05-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Herabstufung | Mizuho | Buy → Neutral |
| 2017-07-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Eingeleitet | Wells Fargo | Outperform |
| 2017-04-07 | Bestätigt | Mizuho | Buy |
| 2017-02-22 | Bestätigt | Barclays | Equal Weight |
| 2016-11-04 | Bestätigt | Mizuho | Buy |
| 2016-10-24 | Bestätigt | Wedbush | Neutral |
| 2016-10-10 | Bestätigt | Mizuho | Buy |
| 2016-09-27 | Bestätigt | WallachBeth | Hold |
Alle ansehen
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
Ironwood Pharmaceuticals (IRWD) price target increased by 28.97% to 7.04 - MSN
Ironwood Pharmaceuticals Inc expected to post earnings of 24 cents a shareEarnings Preview - TradingView
Ironwood Pharmaceuticals (IRWD) Highlights Provider Insights on TPN for SBS Treatment - GuruFocus
Why fewer TPN days matter: doctors cite infection, pain in short bowel syndrome - Stock Titan
MSN Money - MSN
Earnings Preview: IRWD to Report Financial Results Pre-market on May 07 - Moomoo
IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Press Release: Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call - Moomoo
Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call - ChartMill
IRWD Technical Analysis | Trend, Signals & Chart Patterns | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Ironwood Pharmaceuticals (IRWD) Projected to Post Earnings on Wednesday - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 7.3%Here's What Happened - MarketBeat
[ARS] IRONWOOD PHARMACEUTICALS INC SEC Filing - Stock Titan
Ironwood (NASDAQ: IRWD) seeks 10M more equity plan shares in 2026 proxy - Stock Titan
Ironwood Pharmaceuticals (IRWD) price target increased by 10.31% to 5.46 - MSN
Book value per share of Ironwood Pharmaceuticals, Inc. Class A – SWB:I76 - TradingView
Bank of America (NASDAQ: IRWD) reports 6.1% stake in Ironwood Pharmaceuticals - Stock Titan
IRWD Price Today: Ironwood Pharmaceuticals, Inc.Stock Price, Quote & Chart | MEXC - MEXC Exchange
Ironwood (IRWD) to Present Landmark Survey Data at DDW 2026 - GuruFocus
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutritio - PharmiWeb.com
Zacks Research Has Bearish Estimate for IRWD Q2 Earnings - MarketBeat
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026 - Yahoo Finance
Zacks Research Issues Positive Outlook for IRWD Earnings - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 6%Here's What Happened - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Update - MarketBeat
Ironwood Pharmaceuticals (IRWD) Stock Put Call Ratio (Momentum Building) 2026-04-15Trading Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 7.8% HigherStill a Buy? - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap UpWhat's Next? - MarketBeat
Ironwood (IRWD) is one of the most attractive small-cap drug manufacturers, here is why - MSN
What events could move Ironwood Pharmaceuticals (IRWD) Stock next | Price at $3.58, Down 1.52%High Yield Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
New Highs: Is Ironwood Pharmaceuticals Inc affected by consumer sentimentM&A Rumor & Consistent Profit Alerts - baoquankhu1.vn
Is trend weakening for Ironwood Pharmaceuticals (IRWD) Stock | Price at $3.46, Down 1.98%Swing Signals - Cổng thông tin điện tử Tỉnh Sơn La
Breakout Move: Will Ironwood Pharmaceuticals Inc outperform the market in YEAR2026 Chart Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Will Ironwood Pharmaceuticals (IRWD) Stock Miss Expectations | IRWD Q4 Earnings: Misses Estimates by $0.02Social Buy Zones - UBND thành phố Hải Phòng
Support Test: Does Ironwood Pharmaceuticals Inc have consistent dividend growth2026 EndofMonth & High Win Rate Trade Tips - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5.8%Time to Sell? - MarketBeat
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
2.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):